Prowess Funding: How Much Did They Raise & Key Investors

How Much Did Prowess Raise?
Funding & Key Investors

Prowess, a developer of radiation oncology software solutions, has secured $247K in total capital, with its most recent financing round bringing in $247K. This major strategic investment underscores the company's significant progress in the competitive healthcare technology sector. The company's financial trajectory indicates a strong position for continued expansion and innovation in its field.

What is Prowess?

Prowess

Software

Healthcare Software

Prowess Inc., based in Concord, California, is a prominent innovator in radiation oncology software. The company's product suite includes Panther TPS, offering advanced planning modules like VMAT, IMRT, and Brachytherapy, alongside Panther OIS for streamlined oncology center operations. These solutions are vendor-neutral, possess 510(k) clearance, and adhere to ISO 13485 standards, catering to oncology centers and healthcare facilities seeking sophisticated radiation therapy technology.

How much funding has Prowess raised?

Prowess has raised a total of $247K across 1 funding round:

2021

Debt

$247K

Debt (2021): $247K with participation from PPP

What's next for Prowess?

With its recent large-scale late-stage funding, Prowess is poised for accelerated growth and market penetration. The strategic investment is expected to fuel further development of its radiation oncology software, enhance operational efficiencies for its clients, and potentially expand its market reach. This capital infusion will likely support Prowess in solidifying its position as a leader in providing advanced, vendor-neutral solutions for radiation therapy.

See full Prowess company page

See More Financial Insights